LaNova Australia Pty Limited
2 clinical trials · Sponsor
◉ Watch LaNova Australia Pty Limited
| Record | Firm | Date |
|---|---|---|
| Study of LaNova Medicines(LM)-302 in Combination With Toripalimab in Patients With Advanced Solid Tumors (NCT05188664) | LaNova Australia Pty Limited | 2022-05-10 |
| Study of LM-108 as a Single Agent or in Combination With Anti-PD-1 Antibody in Subjects With Advanced Solid Tumours (NCT05199753) | LaNova Australia Pty Limited | 2022-03-16 |
Track LaNova Australia Pty Limited automatically
Every clearance here is in the API, with alerts when new ones post.